Infectech, Inc., reports validation of mycobacteria avium complex kit.

2004 NOV 29 - (NewsRx.com & NewsRx.net) -- Nutra Pharma Corp., (OTCBB: NPHC) Infectech, Inc. (Pink Sheets: IFEC) has received further verification of its technology by Dr. Paul Hyman of Ohio State University.

Hyman has achieved the identification of Mycobacteria avium complex (MAC) using DNA amplification in a much shorter time than can be accomplished with current methodology.

"M. avium could be detected significantly sooner than expected for normal culture techniques," stated Hyman, PhD. Hyman is the primary investigator in Infectech's ongoing validation studies. "Sufficient DNA for PCR (gene amplification) could be extracted from paraffin that had no visible colonies on it," he continued.

Mycobacterium avium and Mycobacterium intracellulare are very similar bacteria which are usually …